Stonebridge Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-40,235
| Closed | -$1.34M | – | 141 |
|
2017
Q2 | $1.34M | Buy |
40,235
+14,070
| +54% | +$468K | 0.51% | 50 |
|
2017
Q1 | $840K | Buy |
26,165
+8,955
| +52% | +$287K | 0.34% | 60 |
|
2016
Q4 | $624K | Buy |
+17,210
| New | +$624K | 0.26% | 66 |
|
2016
Q1 | – | Sell |
-3,600
| Closed | -$236K | – | 167 |
|
2015
Q4 | $236K | Hold |
3,600
| – | – | 0.1% | 142 |
|
2015
Q3 | $203K | Hold |
3,600
| – | – | 0.09% | 147 |
|
2015
Q2 | $213K | Hold |
3,600
| – | – | 0.09% | 151 |
|
2015
Q1 | $224K | Hold |
3,600
| – | – | 0.09% | 149 |
|
2014
Q4 | $207K | Buy |
+3,600
| New | +$207K | 0.08% | 168 |
|
2014
Q2 | – | Sell |
-6,471
| Closed | -$342K | – | 191 |
|
2014
Q1 | $342K | Sell |
6,471
-5,629
| -47% | -$297K | 0.14% | 138 |
|
2013
Q4 | $485K | Buy |
12,100
+500
| +4% | +$20K | 0.19% | 106 |
|
2013
Q3 | $438K | Buy |
11,600
+300
| +3% | +$11.3K | 0.2% | 108 |
|
2013
Q2 | $443K | Buy |
+11,300
| New | +$443K | 0.21% | 106 |
|